What Is/Charitable Organization/San Jose/Make A Donation
Health Care & Social Assistance sector comprises firms providing health care and social assistance for individuals. The sector includes both health care and social assistance because it is sometimes difficult to distinguish between the boundaries of these two activities. The industries in this sector are arranged on a continuum starting with providing medical care exclusively, continuing with those providing health care and social assistance and finally finishing with only social assistance. The services provided in this sector are delivered by trained health practitioners and social workers with requisite experience. JDRF works towards a day when there is no more type 1 diabetes. Type 1 diabetes is usually diagnosed in children and young adults, and was previously known as juvenile diabetes. In type 1 diabetes, the body does not produce insulin. Diabetes – is a problem with your body that causes blood glucose (sugar) levels to rise higher than normal. This is also called hyperglycemia. When you eat your body breaks food down into glucose and sends it into the blood. Insulin then helps move the glucose from the blood into your cells. When glucose enters your cells, it is either used as fuel for energy right away or stored for later use. In a person with diabetes, there is a problem with insulin. But, not everyone with diabetes has the same problem. There are different types of diabetes – type 1, type 2, and a condition called gestational diabetes, which happens during pregnancy. If you have diabetes, your body either doesn’t make enough insulin, it can’t use the insulin it does make very well, or both. See full list of Video Credits http://broadcaster.beazil.net/public/credits/youtube/videos/41902 San Jose, located in northern California in the Santa Clara Valley, is the third-largest city in the state (930,000) and the eleventh-largest in the nation. The oldest city in the state, San Jose was its one-time capital shortly after California became a US territory. The gold rush of 1849 and the arrival of railroads in the 1860s both created significant growth, making San Jose a major commercial center for the area’s agricultural products. Agriculture is still a large part of the city’s economy, with wine production and food processing/distribution among its leading industries. But it’s technology that has made San Jose what it is today, the largest city in northern California and the heart of the Silicon Valley, known for its prominence in the development of semiconductors and computer-related technology. People with T1D would never benefit from JDRF-funded innovations without our donors. The work to create transformational therapies to help people live with T1D cannot—and must not—be allowed to stop because dedicated researchers lack funds. Laboratory studies that are unlocking the mysteries of T1D and accelerating progress toward a cure and prevention must continue. With the generous help of supporters, JDRF is pursuing a diversified, dynamic research agenda that is moving us ever closer to a world without T1D. JDRF is committed to doing the greatest good, for the largest number of people, in the shortest amount of time so we understand the importance of funding these trials. Today more than 50 human trials, studying life-changing drugs, treatments and devices, are under way with our support. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
Let us mention the main issues –
scientific community,engage,low blood glucose,A1C Test,Clinicians,T1D burden,Greater Louisville Walk,VLDL cholesterol,Derek Rapp,Advocacy,EsTiD,Type 1 Diabetes,Cure Diabetes,Scientific,diabetes educator,treatment therapies,GMP,storing insulin,Glucose,low-density lipoprotein cholesterol,Get Personal Support,OGTT,GLP-1 agonists,sugar breakdown,blood glucose level,T1D Progression,Prevention of diabetes complications,diabetic,nonprofit funder,Inhaled Insulin,oral hypoglycemic agents,Dymelor,treatment,high blood glucose,TypeOnesie,US-CA,EDIC Study,Political advocacy,Team Research,Treatment research,symptoms of T1D,uncontrolled hyperglycemia,Research Pathways,noninsulin-dependent diabetes mellitus,gestational diabetes mellitus,Insulin,Diabetes and Pregnancy,American Diabetes Association,very-low-density lipoprotein.